MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 4 filers reported holding MEDICINES CO in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $34,750,000 | -9.0% | 409,112 | -46.5% | 0.10% | -12.8% |
| Q3 2019 | $38,201,000 | +119.0% | 764,012 | +59.7% | 0.11% | +131.9% |
| Q2 2019 | $17,446,000 | +26.6% | 478,373 | -2.9% | 0.05% | +27.0% |
| Q1 2019 | $13,776,000 | +61.0% | 492,873 | +10.3% | 0.04% | +48.0% |
| Q4 2018 | $8,556,000 | -18.9% | 447,035 | +26.7% | 0.02% | -7.4% |
| Q3 2018 | $10,554,000 | -18.5% | 352,868 | 0.0% | 0.03% | -15.6% |
| Q2 2018 | $12,950,000 | -15.6% | 352,868 | -24.3% | 0.03% | -15.8% |
| Q1 2018 | $15,346,000 | +20.5% | 465,863 | 0.0% | 0.04% | +26.7% |
| Q4 2017 | $12,737,000 | -26.2% | 465,863 | 0.0% | 0.03% | -23.1% |
| Q3 2017 | $17,256,000 | -42.5% | 465,863 | -41.0% | 0.04% | -45.8% |
| Q2 2017 | $29,990,000 | -38.1% | 789,014 | -20.4% | 0.07% | -40.0% |
| Q1 2017 | $48,455,000 | +35.3% | 990,899 | -6.1% | 0.12% | +31.9% |
| Q4 2016 | $35,808,000 | -7.0% | 1,055,029 | +3.4% | 0.09% | -6.2% |
| Q3 2016 | $38,519,000 | +106.3% | 1,020,629 | +83.9% | 0.10% | +102.1% |
| Q2 2016 | $18,668,000 | – | 555,099 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,778,742 | $138,680,000 | 22.51% |
| Sarissa Capital Management LP | 1,922,000 | $70,537,000 | 14.14% |
| Antipodean Advisors LLC | 165,500 | $6,074,000 | 7.66% |
| Boxer Capital, LLC | 1,250,000 | $45,875,000 | 5.19% |
| BRIDGER MANAGEMENT, LLC | 2,604,965 | $95,602,000 | 5.18% |
| Slate Path Capital LP | 1,730,000 | $63,491,000 | 4.80% |
| HighVista Strategies LLC | 268,240 | $9,844,000 | 4.44% |
| Camber Capital Management LP | 2,000,000 | $73,400,000 | 2.82% |
| Lion Point Capital, LP | 727,205 | $26,688,000 | 2.40% |
| THREE BAYS CAPITAL LP | 1,360,560 | $49,933,000 | 1.94% |